Previous studies show that EMMPRIN can induce cancer aggressiveness and angiogenesis via up-regulating the expressions of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR), and promote invasion and metastasis by the up-regulation of matrix metalloprotease (MMP) [19]. The gene discussed is EGFR; the disease is cancer.